Antibiotic lock solutions allow less systemic antibiotic exposure and less catheter malfunction without adversely affecting antimicrobial resistance patterns

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Hemodialysis international. International Symposium on Home Hemodialysis

• Publication date

  2013-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1542-4758.2012.00717.xPMID 22716190
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Healthcare Infection Control Practices Advisory Committee

  2012cited by this paper
• Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator.

  2011cited by this paper
• A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis.

  2010cited by this paper
• Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis.

  2010cited by this paper
• Prophylaxis of catheter-related bacteremia using tissue plasminogen activator–tobramycin locks

  2009cited by this paper
• Effect of antimicrobial locks for tunneled hemodialysis catheters on bloodstream infection and bacterial resistance: a quality improvement report.

  2009cited by this paper
• The role of chelators in preventing biofilm formation and catheter-related bloodstream infections

  2008cited by this paper
• Comparison of tissue plasminogen activator-antibiotic locks with heparin-antibiotic locks in children with catheter-related bacteraemia.

  2008cited by this paper
• Radiologically placed tunneled internal jugular catheters in the management of chronic hemodialysis and long-term infusion therapies in the pediatric population.

  2007cited by this paper
• Hemodialysis catheter-related bacteremia in children: increasing antibiotic resistance and changing bacteriological profile.

  2007cited by this paper
• Central venous catheters as a vascular access modality for pediatric hemodialysis

  2007cited by this paper
• Intravascular catheters and biofilm control.

  2007cited by this paper
• Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia.

  2006cited by this paper
• Predictors and outcome of catheter-related bacteremia in children on chronic hemodialysis

  2006cited by this paper
• Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study.

  2006cited by this paper
• Clinical practice guidelines for vascular access.

  2006cited by this paper
• Vascular access survival in children and young adults receiving long-term hemodialysis.

  2005cited by this paper
• Experience with Autogenous Arteriovenous Access for Hemodialysis in Children and Adolescents

  2005cited by this paper
• Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients.

  2005cited by this paper
• The spectrum of infection-related morbidity in hospitalized haemodialysis patients.

  2005cited by this paper
• Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial.

  2005cited by this paper
• Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients.

  2004cited by this paper
• Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution.

  2004cited by this paper
• Long-term survival of dialysis patients with bacterial endocarditis in the United States.

  2004cited by this paper
• Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen.

  2004cited by this paper
• Vascular access results from the Dialysis Outcomes and Practice Patterns Study (DOPPS): performance against Kidney Disease Outcomes Quality Initiative (K/DOQI) Clinical Practice Guidelines.

  2004cited by this paper
• Catheter-related infections in children treated with hemodialysis

  2004cited by this paper
• Locking of tunneled hemodialysis catheters with gentamicin and heparin.

  2004cited by this paper
• Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution.

  2003cited by this paper
• Microsurgery in Children for Creation of Arteriovenous Fistulas in Renal and Non‐renal Diseases

  2003cited by this paper
• Antimicrobial lock therapy for catheter-related bacteraemia among patients on maintenance haemodialysis.

  2002cited by this paper
• Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study.

  2002cited by this paper
• Vascular access use in Europe and the United States: results from the DOPPS.

  2002cited by this paper
• Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution.

  2002cited by this paper
• Guidelines for the prevention of intravascular catheter-related infections.

  2002cited by this paper
• Vancomycin and Ceftazidime Bioactivities Persist for at Least 2 Weeks in the Lumen in Ports: Simplifying Treatment of Port-Associated Bloodstream Infections by Using the Antibiotic Lock Technique

  2001cited by this paper
• Unraveling the realities of vascular access: the Network 11 experience.

  2000cited by this paper
• Survival and complications of cuffed catheters in children on chronic hemodialysis

  1999cited by this paper
• Management of bacteremia associated with tunneled-cuffed hemodialysis catheters.

  1999cited by this paper
• Bacteremia associated with tunneled, cuffed hemodialysis catheters.

  1999cited by this paper
• Septicemia in dialysis patients: incidence, risk factors, and prognosis.

  1999cited by this paper
• Stability of Antibiotics Used for Antibiotic-Lock Treatment of Infections of Implantable Venous Devices (Ports)

  1999cited by this paper
• Catheter-Related Bacteremia and Outcome of Attempted Catheter Salvage in Patients Undergoing Hemodialysis

  1997cited by this paper
• Hemodialysis catheter survival and complications in children and adolescents

  1997cited by this paper
• A clustering of epidural abscesses in chronic hemodialysis patients: risks of salvaging access catheters in cases of infection.

  1996cited by this paper
• Hemodialysis access in the pediatric patient population.

  1994cited by this paper
• Successful treatment of haemodialysis catheter-related sepsis without catheter removal.

  1993cited by this paper
• Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement.

  1993cited by this paper
• Biofilms on indwelling vascular catheters

  1992cited by this paper
• Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients.

  1988cited by this paper

• Antibiotic lock solutions as adjunct therapy for catheter-related blood stream infections in pediatric hemodialysis patients

  2024cites this paper
• Infectious Complications of Hemodialysis in Children

  2021cites this paper
• Development and implementation of an antimicrobial lock therapy guideline in a pediatric hospital.

  2018cites this paper
• Infections in Pediatric Patients with End-Stage Renal Disease

  2018cites this paper
• Catheter-Related Bloodstream Infection

  2017cites this paper
• Chapter 72 – Vascular Access in Children

  2017cites this paper
• We Avoid Antibiotic Lock Solutions due to Fear of Antibiotic Resistance

  2016cites this paper
• Hemodialysis Vascular Access

  2016cites this paper
• An Ethanol/Sodium Citrate Locking Solution Compared to Heparin to Prevent Hemodialysis Catheter-Related Infections: a Randomized Pilot Study

  2016cites this paper
• Systematic review and meta-analysis on management of hemodialysis catheter-related bacteremia.

  2014influential citation
• Reduction of Central Line–Associated Bloodstream Infections in a Pediatric Hematology/Oncology Population

  2014cites this paper
• Attributable costs of central line-associated bloodstream infections in a pediatric hematology/oncology population.

  2013cites this paper